Adamed Pharma is the most innovative company on the Rzeczpospolita 2000 List

Adamed Pharma was recognized as the most innovative company in the prestigious 2000 List ranking published by the Rzeczpospolita. This year's edition of the ranking, presented on December 2, 2024 during a ceremonial gala, distinguished the leaders of the Polish economy. The title received by Adamed Pharma is a recognition of the company's consistent strategy, which is based on investing in research and development.

The award for the most innovative company from the 2000 List of Rzeczpospolita was awarded by a jury consisting of scientists from the Warsaw School of Economics and editors of Rzeczpospolita. Adamed Pharma is thus among the companies that set new standards in Polish business, combining innovation with a responsible approach to doing business. Over the last two decades, the company has invested PLN 2.2 billion in research and development, developing therapies and solutions that have a significant impact on improving the quality of  patients’ lives in Poland and around the world.

The award for the most innovative company was received during the gala by Paweł Roszczyk – Member of the Management Board, Managing Director of Adamed Pharma.

"Adamed Pharma was created thanks to innovation and Polish scientific thought – this is our foundation, it is our DNA. We are currently implementing six innovative projects that concern original drugs in the areas of neuropsychiatry, oncology and vaccines. For three of these projects, we have already started clinical trials. At the same time, we invest heavily in research and development. On November 22, we opened modern laboratories that will be dedicated to the development of inhaled drugs. It is the only platform of this type in Poland, under which work will be carried out simultaneously on as many as six products cooperating with dedicated inhalers. In addition, we have recently received the prestigious Prix Galien Polska award for the best product of the second generation, which was awarded to the combination of Sitagliptin + Metformin XR. This is further proof of the direction in which we are investing and developing our business – we focus on developing combinations of 2-3 substances in one drug, which is aimed at improving patient compliance and thus achieving better therapeutic results. That is why I am very pleased that our efforts in the area of innovation have been appreciated by awarding us the title of the most innovative company within the 2000 List of Rzeczpospolita. On behalf of Adamed Pharma, I would like to thank the editorial team and the award committee for this unique distinction" said Paweł Roszczyk.  

The 2000 List of Rzeczpospolita is one of the most important economic rankings in Poland, which for 22 years has been awarding the largest and most dynamically developing companies in the country. This prestigious ranking not only evaluates the financial performance of companies, but also their contribution to innovation, social responsibility and sustainable development. Every year, this publication becomes a barometer of Polish business, indicating companies that set new standards and contribute to strengthening Polish's position in the international arena.

Adamed Pharma's distinction in the ranking confirms the high quality of the company's activities in the field of innovation, as well as its key role in shaping the future of the pharmaceutical and biotechnology sector in Poland.

We invite you to read the full results of the List of 2000 at: https://rankingi.rp.pl/lista2000/2024

Photo report: Cezary Piwowarski